Skip to content

Drug interactions

Maprotiline + Metformin-pioglitazone

Severity: Minor

Maprotiline and Metformin-pioglitazone: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Maprotiline, a tetracyclic antidepressant, may alter glucose control and has rarely been linked to changes in glycemia in diabetic patients. The effect is inconsistent and usually small.

What this interaction means in plain words

Maprotiline and Metformin-pioglitazone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Maprotiline belongs to Central Nervous System; Metformin-pioglitazone belongs to Endocrine.

Evidence level: Low

Why it happens

Mechanism is not well established; may involve effects on insulin secretion, appetite and weight.

What to do

Monitor blood glucose when maprotiline is started or stopped and adjust antidiabetic therapy if needed.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Maprotiline and Metformin-pioglitazone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Maprotiline with Metformin-pioglitazone?

MediHelp rates the interaction as minor. Maprotiline and Metformin-pioglitazone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Maprotiline, a tetracyclic antidepressant, may alter glucose control and has rarely been linked to changes in glycemia in diabetic patients. The effect is inconsistent and usually small.

How serious is the interaction between Maprotiline and Metformin-pioglitazone?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when maprotiline is started or stopped and adjust antidiabetic therapy if needed.

What other medicines interact with Metformin-pioglitazone?

MediHelp also lists interactions of Metformin-pioglitazone with, for example, Contrast media, Diatrizoate meglumine / diatrizoate, Diatrizoate. The full list is on the Metformin-pioglitazone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in